SEARCH

SEARCH BY CITATION

References

  • Altincicek B & Vilcinskas A (2006) Metamorphosis and collagen-IV-fragments stimulate innate immune response in the greater wax moth, Galleria mellonella. Dev Comp Immunol 30: 11081118.
  • Bougnoux P (1999) n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 2: 121126.
  • Calder PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S1519S.
  • Calviello G, Palozza P, Franceschelli P & Bartoli GM (1997) Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids 32: 10751083.
  • Carballeira NM (2008) New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog Lipid Res 47: 5061.
  • Desbois A & Smith V (2010) Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 85: 16291642.
  • Drevinek P & Mahenthiralingam E (2010) Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16: 821830.
  • Hilmarsson H, Traustason BS, Kristmundsdóttir T & Thormar H (2007) Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels. Arch Virol 152: 22252236.
  • Huang CB, George B & Ebersole JL (2010) Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol 55: 555560.
  • Kang KS, Wang P, Yamabe N, Fukui M, Jay T & Zhu BT (2010) Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS ONE 5: e10296.
  • Livak KJ & Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 25: 402408.
  • Mahenthiralingam E, Urban TA & Goldberg JB (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3: 144156.
  • Martinez JG, Waldon M, Huang Q et al. (2009) Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa. Biochem J 419: 193200.
  • Mimoun M, Coste TC, Lebacq J, Lebecque P, Wallemacq P, Leal T & Armand M (2009) Increased tissue Arachidonic acid and reduced Linoleic acid in a mouse model of Cystic Fibrosis are reversed by supplemental glycerophospholipids enriched in Docosahexaenoic Acid. J Nutr 139: 23582364.
  • Mizota A, Sato E, Taniai M, Adachi-Usami E & Nishikawa M (2001) Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci 42: 216221.
  • NCCLS (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th edn. National Committee for Clinical Laboratory Standards, Wayne, PA.
  • Nzula S, Vandamme P & Govan JR (2002) Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 50: 265269.
  • Olveira G, Olveira C, Acosta E, Espíldora F, Garrido-Sánchez L, García-Escobar E, Rojo-Martinez G, Gonzalo M & Soriquer F (2010) Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch Bronconeumol 46: 7077.
  • Rose H, Baldwin A, Dowson CG & Mahenthiralingam E (2009) Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 63: 502510.
  • Rosenberg M, Gutnick D & Rosenberg E (1980) Adherence of bacteria to hydrocarbons: a simple method for measuring cell surface hydrophobicity. FEMS Microbiol Lett 9: 2933.
  • Seed KD & Dennis JJ (2008) Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia Complex. Infect Immun 76: 12671275.
  • Shin SY, Bajpai VK, Kim HR & Kang SC (2007) Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria. Int J Food Microbiol 113: 233236.
  • Strandvik B (2010) Fatty acid metabolism in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 83: 121129.
  • Thormar H & Hilmarsson H (2007) The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids 150: 111.
  • Tiesset H, Pierre M, Desseyn J-L, Guéry B, Beermann C, Galabert C, Gottrand F & Husson MO (2009) Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr 139: 8289.
  • Willumsen N, Hexeberg S, Skorve J, Lundquist M & Berge RK (1993) Docosahexaenoic acid shows no triglyceride lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 34: 1322.
  • Wojda I, Kowalski P & Jakubowicz T (2009) Humoral immune response of Galleria mellonella larvae after infection by Beauveria bassiana under optimal and heat-shock conditions. J Insect Physiol 55: 525531.
  • Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH & Kim WG (2005) Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 2005(579): 51575162.